Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Ptc Therapeutics (PTCT)

15.94 -0.31 (-1.91%)

12-12 16:00

Open:

16.25

Pre. Close:

16.25

High:

16.37

Low:

15.6

Volume:

629,534

Market Cap:

661M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

16.16 - 16.68

16.68 - 17.19

Low:

14.19 - 14.67

14.67 - 15.15

Close:

14.87 - 15.68

15.68 - 16.49

Technical analysis  (as of: 2017-12-12 4:52:59 PM)

Overall:

      

Stoxline posted a STRONG SELL today, downgraded from higher rating. This stock seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 19.07     One year: 20.12

Support:

Support1: 14.87    Support2: 12.37

Resistance:

Resistance1: 16.33    Resistance2: 17.23

Pivot:

16.11

Moving Averages:

MA(5): 16.35     MA(20): 15.98

MA(100): 18.28     MA(250): 15.32

MACD:

MACD(12,26): -0.18     Signal(12,26,9): -0.29

%K %D:

%K(14,3): 61.88     %D(3): 74.98

RSI:

RSI(14): 44.77

52-Week:

High: 22  Low: 8.12  Change(%): 29.3

Average Vol(K):

3-Month: 127519  10-Days 68495

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
PTCT has closed above bottom band by 36.4%. Bollinger Bands are 61.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to PTCT's normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 29 Sep 2017 14:55:34 GMT
Investors want PTC Therapeutics to be the next Sarepta

Tue, 12 Dec 2017 15:00:00 GMT
Update in Lawsuit for Investors in NASDAQ:PTCT shares against PTC Therapeutics ...

Tue, 12 Dec 2017 22:18:45 GMT
Comparing PTC Therapeutics (PTCT) & Its Competitors

Tue, 12 Dec 2017 15:45:00 GMT
What The Market Is Missing About Canadian Solar Inc. (CSIQ), PTC Therapeutics ...

Tue, 05 Dec 2017 15:56:15 GMT
Schubert Firm Launches Investigation Of PTC Therapeutics, Inc. Executives For ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

41.49

Shares Float (M)

30.05

% Held by Insiders

3.96

% Held by Institutions

88.00

Shares Short (K)

8640

Shares Short Prior Month (K)

8180

Stock Financials

EPS

-3.050

EPS Est. Current Year

-2.350

EPS Est. Next Year

-1.970

EPS Est. Next Quarter

-0.500

Forward EPS

-2.069

Book Value (p.s.)

3.520

PEG Ratio

0.74

Profit Margin

-75.64

Operating Margin

-65.23

Return on Assets (ttm)

-17.6

Return on Equity (ttm)

-74.9

Qtrly Rev. Growth

82.1

Gross Profit (p.s.)

1.993

Sales Per Share

EBITDA (p.s.)

-1.923

Qtrly Earnings Growth

Operating Cash Flow (M)

-44.67

Levered Free Cash Flow (M)

-15.10

atoplab.com

Valuation

P/E

-5.23

P/E Growth Ratio

-0.02

P/BV

4.53

P/S

174498832.00

P/CF

-14.81

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.